Serum Life Sciences invests in Oxford Biomedica plc

676
2
Oxford Biomedica plc, a leading gene and cell therapy group, Sep. 22 announces that Serum Life Sciences Ltd, a subsidiary company of Serum Institute of India Pvt Ltd, agreed to invest just over GBP50 million in the Group in return for new ordinary shares representing 3.9% of the outstanding shares

You need to subscribe for access to restricted content.

Sign up
Login:
Password:
Forgot your password?